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In this issue ofCell Host &Microbe, Pijlman et al. define the structure andmechanism of generation of a small
viral noncoding RNA present in flavivirus-infected cells that has a marked impact on the fate of infected cells
and virulence in vivo.Flaviviruses are a family of small RNA
viruses that cause a spectrum of severe
diseases in humans, including encephali-
tis, hemorrhagic fever, and hepatitis (Lin-
denbach et al., 2007). These viruses share
a similar genetic organization and overall
strategy for replication of their positive-
stranded viral genome. Approximately
70 members of the flavivirus genus have
been identified and include West Nile
virus (WNV), yellow fever virus (YFV),
and dengue virus (DENV). Together, flavi-
viruses are responsible for more than
50 million human infections each year
and represent a significant threat to global
health.
Flavivirus virions encapsidate an11 kb
genome that contains a type I cap
structure, is nonpolyadenylated, and en-
codes a single open reading frame (Lin-
denbach et al., 2007). Translation of the
viral genome is followed by cleavage of
the polyprotein by both cellular and viral
proteases into ten functionally distinct
proteins, including three structural pro-
teins and seven nonstructural proteins
that are involved in viral genome replica-
tion, polyprotein processing, and modula-
tion of the host cell response to infection.
The open reading frame is flanked on
each end by untranslated regions (UTRs)
containing stable RNA structures that
facilitate intramolecular interactions be-
tween the two ends of the genome and
mediate interactions with an expanding
list of host proteins (Paranjape and Harris,
2007 and references within). Together,
the activities of the 50 and 30UTRs contrib-
ute to the regulation of viral translation,
genomic RNA replication, and modulation
of the host stress response (Emara
and Brinton, 2007). Replication of flavivi-
ruses occurs in the cytoplasm of target
cells in association with virus-induced512 Cell Host & Microbe 4, December 11, 20membrane structures. Curiously, analy-
ses of the viral RNA species present in
flavivirus-infected cells have identified
a small positive-sense viral RNA species
distinct from expected replication inter-
mediates or products (Lin et al., 2004
and references within). However, the ori-
gin and potential function of this small
fragment of the viral genome has not
been previously investigated in molecular
detail.
Kunjin virus (WNVKUN) is a less-
pathogenic Australian strain of WNV that
has been studied extensively as a model
of flavivirus replication. The significant
advances in the molecular biology of
flaviviruses that arose from the study of
WNVKUN were made possible, in part, by
the development and application of inno-
vative molecular clone technologies, in-
cluding a variety of vectors that express
infectious viral genomes and truncated,
self-replicating forms of the viral genome
engineered to express reporter genes
(called replicons) (Westaway et al., 2003).
In this issue, Pijlman et al. (2008) em-
ploy a battery of these molecular tools in
an elegant series of experiments that
investigate the structure of the enigmatic
small RNA fragment present in infected
cells (referred to as the subgenomic flavi-
virus RNA [sfRNA]), its generation in cells,
and its role in viral replication and patho-
genesis. Using a library of WNVKUN repli-
cons that contain an assortment of dele-
tions and mutations, they demonstrate
that the generation of sfRNA is not a by-
product of flavivirus RNA replication, does
not require the activity of any of the flavivi-
rus gene products, and is dependent only
on the presence of the 30UTR sequence.
They next mapped the 50 end of the sfRNA
to the base of a highly structured and con-
served element within the 30UTR called08 ª2008 Elsevier Inc.SL-II. Thus, the 525 nucleotide length of
sfRNA corresponds to a molecule that
starts at SL-II and terminates at the 30
end of the viral genome.
To determine how sfRNA are gener-
ated, the authors explored the possibility
that this small fragment was a product of
the degradation of the viral genome and
investigated a link between sfRNA produc-
tion and the cellular mRNA degradation
machinery (Beckham and Parker, 2008).
Cells degrade mRNA using two distinct
pathways and can do so from either end
of the message. In one pathway, the 30
polyadenosine (poly(A)) tail is removed,
and the mRNA is degraded in a 30-to-50
direction by an exonuclease-containing
complex called the exosome. Alterna-
tively, mRNA can be recruited into large
aggregates called processing bodies
(P bodies) that contain enzymes required
to remove the poly(A) tail and 50 cap of
the mRNA and then degrade it in a 50-to-
30 direction. The latter enzymatic function
is mediated by the exonuclease XRN1
(Beckham and Parker, 2008).
A role for P bodies in the generation of
sfRNA was suggested by a significant re-
duction in the level of sfRNA in WNVKUN-
infected cells depleted of XRN1. Further-
more, XRN1 colocalized with probes for
the WNVKUN 3
0UTR in infected cells.
Because secondary structure has been
shown to stall XRN1-mediated RNA deg-
radation (Sheth and Parker, 2003), the
authors tested a large panel of mutant vi-
ruses to investigate whether the complex
structures present in the WNVKUN 3
0UTR,
particularly SL-II, block complete degra-
dation of the genome and promote the
formation of sfRNA. Viruses with muta-
tions that destabilize or eliminate the
SL-II hairpin exhibit decreased sfRNA
production. In many of these constructs,
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pearance of fragments that were smaller
than sfRNA. These experiments sug-
gested that SL-II blocks XRN1-mediated
degradation, and, in its absence, degra-
dation proceeds until XRN1 stalls at
downstream structured elements. In
agreement with this hypothesis, sfRNA
was resistant to digestion by XRN1
in vitro. Importantly, not all RNA struc-
tures block XRN1 degradation. While ex-
periments with other members of the flavi-
virus genus that encode structures similar
to SL-II revealed RNA fragments consis-
tent with the size of sfRNA, this small
RNA was not observed in cells replicating
HCV or pestivirus RNA. The properties of
structures capable of protecting RNA
from XRN1-mediated degradation in
P bodies remain to be determined.
The appearance of the exonuclease-
resistant sfRNA fragment reflects the
demise of individual viral genomes within
the infected cell. The possibility that this
degradation product is not just a waste
product of viral RNA replication but
actually contributes to the virus life cycle
or pathogenesis was also investigated.
Infectious WNVKUN variants encoding
mutations that block the production of
sfRNA were identified. By comparison to
wild-type viruses, these mutants grow to
reduced titers in cell cultures and produce
significantly smaller plaques. Pijlman and
colleagues (Pijlman et al., 2008) found
that this reduction in virus growth and pla-
que size could not be attributed to prob-
lems with several previously defined roles
of the 30UTR. Mutations that prevent
sfRNA production did not dramatically
impact the efficiency with which the viral
genome was translated, replicated, orpackaged into virions. Instead, the
authors provide compelling evidence
suggesting that sfRNA null viruses are
markedly less toxic to cells. More impor-
tantly, these variants were significantly
less pathogenic in a murine model of
infection and disease.
This manuscript demonstrates that an
incomplete degradation product of the
flavivirus genome plays an important role
in the biology of flaviviruses and uncovers
exciting new possibilities for further study.
In mechanistic terms, it will be of interest
to determine the role of sfRNA in the viral
life cycle and how it acts in concert with
the remainder of the genome to promote
cell toxicity and death. Little is known
about the link between flavivirus replica-
tion and P bodies. This study provides
strong evidence supporting an interaction
between the viral genome and P bodies at
some phase of the viral life cycle. How
these interactions are regulated and
whether they play an important role in
the virus life cycle beyond the production
of sfRNA remains to be determined. Prior
work suggests that flavivirus infection re-
sults in the downregulation of P bodies
and the stress granules with which they
interact (Emara and Brinton, 2007). It will
be of significant interest to determine
whether sfRNA modulates interactions
between viral RNA and the cellular TIA-1
and TIAR molecules involved in the as-
sembly of stress granules. This work will
also catalyze studies that explore how
sfRNA increases virulence in vivo. The
production of a small highly structured
RNA molecule certainly has the potential
to compete with the intact genome for
binding to cellular factors. In theory, these
small RNA moieties could differentiallyCell Host & Microbe 4,recognize and antagonize cellular RNA
sensors (e.g., RIG-I, MDA5, TLR3, and
TLR7) that initiate the innate immune
response. Finally, understanding the
behavior of viruses that are unable to
produce sfRNAs may be of significant
practical value. Current strategies for the
development of live attenuated flavivirus
vaccines include the introduction of muta-
tions and/or deletions into the 30UTR
(Whitehead et al., 2007). Insights from the
structure of sfRNA and its as-yet little-
defined role in virulence may be of signif-
icant value in the design of safe and
immunogenic vaccine candidates.
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